Using an app to help manage chronic low-back pain
Official title: Alberta Chiropractic SelfBack Study
Run by University of Alberta · NCT06347991 · Data updated 2026-11-12
This study is testing whether the SelfBack app can help people with chronic low-back pain manage their symptoms better when it's provided through chiropractors in Alberta.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Alberta Academic / other |
| Locations | 1 site (Edmonton, Alberta) |
| Status | Recruiting |
| Started | May 24, 2024 |
| Main results expected | March 15, 2026 |
| Study ends | March 15, 2026 |
| Registry record updated | April 15, 2025 |
| Trial ID | NCT06347991 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Alberta residents aged 18 and older with persistent low-back pain impacting daily activities for over a month.
✕Probably not a fit
Patients with complex back pain requiring direct clinical oversight or those with cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the feasibility of distributing the SelfBack app to patients with chronic low-back pain through chiropractors in Alberta. The SelfBack app is designed to support self-management behaviors and improve patient outcomes related to low-back pain. Chiropractors will be trained to use the app and will identify eligible patients in their practice to participate. The app collects patient data and provides personalized advice to enhance self-management of their condition.
Why it matters
Potential benefit: If successful, this approach could empower patients to better manage their chronic low-back pain and reduce reliance on ineffective medical interventions.
How similar studies have gone: While the use of apps for self-management of chronic pain is gaining traction, this specific approach using the SelfBack app is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Clinician Inclusion Criteria: * Practicing chiropractor in Alberta. * Will have access to ATLAS, ChiroSUITE, or Jane software packages * Must have completed and filed a Privacy Impact Assessment with the Government of Alberta, as identified under the Health Information Act. * Connected to Alberta's electronic health record, Netcare Patient Inclusion Criteria: * Patients of enrolled chiropractors having persistent and/or recurrent LBP defined as those currently having LBP that has impacted daily activities for \> 1 month. I * Alberta resident 18 years of age or older * Must have a personal smartphone with internet access. * Must have a working e-mail address. * Must speak, read, and write English or have regular access to persons who can assist in this regard. Patient exclusion criteria: * Patients who have complex back pain that requires direct clinical oversight. * Patients with cognitive impairments or learning disabilities that limit participation. * Patients with serious mental illness. * Patients who have non-LBP illnesses or conditions that are contraindicated to participation in SelfBack (e.g. exercise). * Patients who have terminal illness * Patients who are unable to take part in exercise/physical activity.
Where it's running
-
University of Alberta
Edmonton, Alberta, Canada Recruiting
Study contacts
- Study coordinator: Greg Kawchuk, PhD
- Email: greg.kawchuk@ualberta.ca
- Phone: 780-492-6891
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.